Publicaciones en colaboración con investigadores/as de Duke Clinical Research Institute (15)

2024

  1. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry

    Journal of Cardiac Failure

  2. Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 457-473

  3. Ischemia Severity, Coronary Artery Disease Extent, and Exercise Capacity in ISCHEMIA

    Circulation, Vol. 150, Núm. 2, pp. 165-167

2023

  1. Impact of Complete Revascularization in the ISCHEMIA Trial

    Journal of the American College of Cardiology, Vol. 82, Núm. 12, pp. 1175-1188

  2. Survival after Invasive or Conservative Management of Stable Coronary Disease

    Circulation, Vol. 147, Núm. 1, pp. 8-19

2022

  1. Assessment of Omecamtiv Mecarbil for the Treatment of Patients with Severe Heart Failure: A Post Hoc Analysis of Data from the GALACTIC-HF Randomized Clinical Trial

    JAMA Cardiology, Vol. 7, Núm. 1, pp. 26-34

  2. Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

    American Heart Journal, Vol. 248, pp. 72-83

  3. Effects of initial invasive vs. initial conservative treatment strategies on recurrent and total cardiovascular events in the ISCHEMIA trial

    European heart journal, Vol. 43, Núm. 2, pp. 148-149

  4. Outcomes With Intermediate Left Main Disease: Analysis From the ISCHEMIA Trial

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 4, pp. E010925

  5. Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial

    Journal of the American College of Cardiology, Vol. 79, Núm. 7, pp. 651-661

2021

  1. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure

    New England Journal of Medicine, Vol. 384, Núm. 2, pp. 105-116

  2. Comparison of Days Alive out of Hospital with Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial

    JAMA Cardiology, Vol. 6, Núm. 9, pp. 1023-1031

2020

  1. Initial invasive or conservative strategy for stable coronary disease

    New England Journal of Medicine, Vol. 382, Núm. 15, pp. 1395-1407

2018

  1. Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry

    Indian Heart Journal, Vol. 70, Núm. 6, pp. 828-835

2016

  1. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists

    British Journal of Haematology, Vol. 174, Núm. 4, pp. 610-623